Male Reproductive

Priapism: ischemic vs non-ischemic management

Clinical Overview and When to Suspect Priapism

— Ischemic (low-flow, veno-occlusive): compartment syndrome of the corpora cavernosa. Painful, rigid, time-sensitive. >90% of cases.

— Non-ischemic (high-flow, arterial): unregulated cavernous arterial inflow, usually post-traumatic (straddle injury, perineal blunt trauma). Painless, partial tumescence, not emergent.

— Stuttering (recurrent ischemic): repeated self-limited ischemic episodes, classically in sickle cell disease.

— Adult male with prolonged erection after intracavernosal injection (alprostadil, papaverine, phentolamine) for ED

— Sickle cell patient with recurrent painful nocturnal erections

— Patient on trazodone, SSRIs, antipsychotics (chlorpromazine, risperidone, olanzapine), prazosin, cocaine, methamphetamine, or PDE-5 inhibitor overdose

— Hematologic malignancy (CML, multiple myeloma) — leukostasis/hyperviscosity

— Recent perineal or penile trauma → think non-ischemic

— Spinal cord injury, pelvic neoplasm

— <4 h: often resolves; observe

— 4–24 h: ischemic priapism — aspirate + irrigate + phenylephrine; tissue still salvageable

— >24–48 h: irreversible corporal smooth muscle necrosis, fibrosis, near-universal ED

— >72 h: aspiration largely futile; proceed to shunt or early penile prosthesis discussion

Board pearl: On Step 3, a painful rigid erection >4 hours is ischemic until proven otherwise — do not delay corporal blood gas and aspiration to chase imaging. Pain + rigidity + recent intracavernosal injection or sickle cell = ischemic; painless + trauma history = high-flow, can wait for outpatient urology and selective arterial embolization.

Definition: Priapism = persistent penile erection >4 hours, unrelated to (or persisting beyond) sexual stimulation. A urologic emergency when ischemic.

Two physiologic categories — must distinguish early:

When to suspect on Step 3:

Why timing matters:

Presentation Patterns and Key History

— Painful, fully rigid erection of corpora cavernosa; glans and corpus spongiosum soft

— Duration clearly stated (the vignette gives you hours — use it)

— Triggers: intracavernosal ED therapy, oral PDE-5 inhibitor + recreational nitrates, sickle cell crisis, new antipsychotic/trazodone, cocaine

— Sleep-related onset typical in sickle cell stuttering priapism

— Young man, straddle injury (bicycle bar, gymnastics, kick to perineum) days to weeks ago

— Painless, partial (not fully rigid) erection, often intermittent

— May report a perineal bruise or hematoma

— Mechanism: laceration of cavernous artery → arterial-lacunar fistula

— Repeated ischemic episodes lasting <4 h, self-resolving

— Strongest association: sickle cell disease (prevalence up to 35% of males)

— Also: thalassemia, hereditary spherocytosis, chronic PDE-5i use

— Exact onset time (drives the management clock)

— Prior episodes and what aborted them

— Medications: trazodone, SSRIs, antipsychotics, prazosin/terazosin, anticoagulants, hydroxyurea

— Erectile dysfunction therapy: injections, intraurethral alprostadil, PDE-5i dosing

— Illicit drugs: cocaine, methamphetamine, MDMA, cannabis

— Hematologic: sickle cell, leukemia (especially CML with WBC >100k), myeloma, TPN with fat emulsions

— Trauma to perineum/genitals

— Spinal cord injury, recent neuraxial anesthesia

— Pelvic or genitourinary malignancy

Step 3 management: The single most decision-changing data point is duration of erection — it determines whether the patient gets bedside aspiration in the ED, a shunt in the OR, or scheduled outpatient embolization. Document it in hours, not vague terms. In sickle cell stuttering disease, also ask about prophylactic regimens (hydroxyurea, oral pseudoephedrine, etilefrine, leuprolide) to guide discharge planning.

Ischemic priapism — classic stem:

Non-ischemic priapism — classic stem:

Stuttering priapism:

Key history to obtain rapidly:

Physical Exam Findings (and Hemodynamic Assessment)

— Vitals: tachycardia and hypertension may reflect pain; hypotension suggests sepsis, sickle crisis, or drug overdose

— Hydration and perfusion status, especially in sickle cell patients

— Mental status (cocaine/meth/antipsychotic toxidromes)

— Ischemic: corpora cavernosa rigid and tender; glans and corpus spongiosum soft and uninvolved (cavernosa-only finding is pathognomonic vs. normal erection where spongiosum also fills). Skin may appear dusky.

— Non-ischemic: corpora partially tumescent, non-tender, compressible; bruit may be auscultated over the perineum; perineal ecchymosis or hematoma supports straddle injury history

— Foreskin retraction to exclude paraphimosis (a true mimic in older men)

— Digital rectal exam if pelvic malignancy or spinal injury suspected

— Splenomegaly, pallor, scleral icterus → sickle/hemolytic

— Massive splenomegaly + leukocytosis → CML with leukostasis

— Track marks, nasal septal erosion → stimulant use

— Neurologic exam: spinal level, anal tone, bulbocavernosus reflex if cord injury suspected

— Ischemic: pO₂ <30 mmHg, pCO₂ >60 mmHg, pH <7.25 — dark, sludgy, deoxygenated blood

— Non-ischemic: pO₂ >90, pCO₂ <40, pH ~7.40 — bright red, arterial-appearing blood

— Aspirate from lateral corpus cavernosum at 2 or 10 o'clock position with 19–21 gauge needle after dorsal nerve block

Key distinction: Rigid + painful + dark aspirate = ischemic, act now. Partial + painless + bright aspirate or perineal bruit = non-ischemic, urology follow-up with selective pudendal arteriography. The exam alone — soft spongiosum and glans with rigid cavernosa — should already tell you this is priapism, not a normal erection.

General exam priorities:

Focused genitourinary exam:

Peripheral and systemic clues:

Bedside hemodynamic of the corpora — corporal blood gas (the "exam" that defines the disease):

Diagnostic Workup — Initial Labs and Bedside Studies

— Performed simultaneously with therapeutic aspiration

— Single most discriminating study between ischemic and non-ischemic

— Do not delay aspiration awaiting imaging in a painful rigid presentation

— CBC with differential — anemia (sickle), leukocytosis with left shift (CML, infection), thrombocytosis

— Reticulocyte count, peripheral smear — sickle cells, blasts, schistocytes

— Hemoglobin electrophoresis if sickle disease not previously confirmed

— Type and screen if shunt or transfusion anticipated

— Coagulation panel (PT/INR, aPTT) — pre-procedure baseline

— Basic metabolic panel — renal function before contrast or phenylephrine dosing

— Urine toxicology — cocaine, amphetamines, cannabinoids

— Beta-hCG: N/A (male) — but consider testosterone if recurrent unexplained

— LDH, bilirubin, haptoglobin if hemolysis suspected

— Baseline rate, rhythm, QT

— Patients with severe HTN, recent MI, CAD, or arrhythmia need cardiac monitoring during intracavernosal sympathomimetic dosing

— Color duplex of cavernosal arteries

— Ischemic: minimal or absent cavernosal arterial flow

— Non-ischemic: high-velocity turbulent flow, often with visible fistula or pseudoaneurysm

CCS pearl: In a CCS-style case, the order set for a painful rigid erection >4 hours should read: IV access, CBC, reticulocyte count, hemoglobin electrophoresis (if not known), BMP, coags, type and screen, urine tox, corporal blood gas with simultaneous aspiration, IV fluids, IV opioid analgesia, supplemental O₂, and urology consult — all clock-advanced in parallel, not sequentially.

Mandatory bedside test: corporal (cavernosal) blood gas

Laboratory workup (send while preparing aspiration tray):

ECG before phenylephrine:

Pregnancy/contrast considerations: not applicable; but renal function relevant if arteriography contemplated for non-ischemic priapism

Bedside ultrasound (optional, useful when diagnosis unclear):

Diagnostic Workup — Advanced and Confirmatory Studies

— Ischemic findings: absent or minimal cavernosal arterial flow; sluggish or no venous outflow; hypoechoic, edematous corpora

— Non-ischemic findings: preserved or increased cavernosal arterial flow; arteriolar-sinusoidal fistula seen as a focal turbulent jet; possible pseudoaneurysm with "yin-yang" sign

— Useful when corporal blood gas equivocal or when patient presents late and aspirate is mixed

— Both diagnostic and therapeutic in non-ischemic priapism

— Identifies the cavernosal artery fistula; allows superselective embolization with autologous clot or absorbable gel foam (preferred to permanent coils to preserve future erectile function)

— Not indicated routinely in ischemic priapism

— Reserved for cases with suspected corporal thrombosis, malignant infiltration (penile metastasis from prostate, bladder, rectum), or to assess viability of corporal smooth muscle before prosthesis placement after prolonged ischemia

— Hemoglobin electrophoresis, G6PD activity

— Bone marrow biopsy if leukemia or myeloma suspected on smear

— JAK2, BCR-ABL when myeloproliferative disease suggested

— Testosterone (free and total), prolactin if suspected pituitary contribution

— Consider sleep study if nocturnal stuttering pattern resists therapy

— Quantitative drug levels rarely change acute management but document for safety

— Review home medication list for serotonergic, alpha-blocking, antipsychotic agents — drives secondary prevention

Board pearl: In a young athlete with painless partial erection after a bicycle injury, the diagnostic and therapeutic study of choice is selective pudendal arteriography with superselective embolization — not corporal aspiration. Aspiration is the wrong answer when the case is high-flow.

Color Doppler ultrasound of the penis and perineum:

Selective internal pudendal arteriography:

MRI of the pelvis/penis:

Hematologic workup (after stabilization, especially in recurrent disease):

Endocrine and metabolic workup (recurrent/stuttering):

Toxicology and medication reconciliation:

Risk Stratification and First-Line Management Logic

— Step 1: Confirm priapism (>4 h, rigid cavernosa, soft spongiosum/glans)

— Step 2: Treat pain and underlying systemic disease (oxygen, IV fluids, analgesia; exchange transfusion considered for sickle but does not delay local therapy)

— Step 3: Perform corporal aspiration + blood gas → classify ischemic vs non-ischemic

— Step 4a: Ischemic → aspiration with saline irrigation, then intracavernosal phenylephrine, then surgical shunt if refractory

— Step 4b: Non-ischemic → conservative management (ice, perineal compression), elective angiographic embolization

— <4 h: observation, treat reversible triggers; many resolve

— 4–6 h: aspiration ± phenylephrine, high success

— 6–24 h: aspiration + phenylephrine, expect lower success; prepare for shunt

— 24–48 h: aspiration usually fails; distal cavernoglanular shunt (Winter, Ebbehoj, T-shunt) ± tunneling (Burnett)

— 48–72 h: proximal shunt or early penile prosthesis discussion (especially if MRI shows necrosis)

— >72 h: erectile function rarely preserved; counsel about prosthesis

— IV hydration, oxygen, analgesia, alkalinization, simple or exchange transfusion to Hb S <30%

— Do not delay aspiration/phenylephrine waiting for transfusion — local and systemic therapies run in parallel

— ASPEN syndrome (Association of Sickle cell, Priapism, Exchange transfusion, Neurologic events) — manage BP carefully post-exchange

Step 3 management: The clock starts at symptom onset, not arrival. If duration is unclear, default to the ischemic algorithm. Concurrent urology consultation is standard, but the ED physician must initiate aspiration and phenylephrine — do not wait for urology to arrive if the corporal gas confirms ischemia and the patient is in pain.

Algorithm for any priapism in the ED:

Time-based decision points for ischemic priapism:

Sickle cell modifiers:

Pharmacotherapy — First-Line Intracavernosal Therapy

— Mechanism: pure alpha-1 agonist → cavernous smooth muscle contraction → detumescence with minimal beta-mediated cardiac effect

— Dilution: 1 mg phenylephrine in 9 mL normal saline → 100 mcg/mL

— Dose: 100–500 mcg (1–5 mL of dilution) intracavernosally every 3–5 minutes

— Max: typically 1 mg over 1 hour; cap lower in cardiovascular disease, elderly, children, MAOI use

— Inject after lidocaine 1% dorsal nerve block and aspiration of 20–60 mL stagnant blood from corpus cavernosum

— Irrigate with cold saline between phenylephrine doses if detumescence partial

— Continuous BP and ECG every 15 minutes for at least 1 hour

— Watch for reflex bradycardia, hypertensive urgency, headache, palpitations, arrhythmia

— Have IV access and labetalol or phentolamine available for hypertensive response

— Epinephrine 1:1,000,000 (rarely used; more arrhythmogenic)

— Etilefrine (not available in US)

— Methylene blue, terbutaline — historic, low efficacy, not recommended first-line

— Oral pseudoephedrine 60–120 mg — useful for very early priapism (<4 h) and stuttering episodes at home

— Oral terbutaline — limited evidence, occasionally used

— Sickle cell: IV fluids, oxygen, opioid analgesia, transfusion to lower HbS

— Leukemia: leukapheresis, hydroxyurea, induction chemotherapy

— Drug-induced: discontinue offending agent

Board pearl: Phenylephrine is the only intracavernosal sympathomimetic recommended first-line by AUA/EAU because of its alpha-1 selectivity. Avoid in uncontrolled hypertension, severe CAD, MAOI use; use lower doses and tighter monitoring in elderly and pediatric sickle cell patients.

Intracavernosal phenylephrine — the agent of choice for ischemic priapism:

Monitoring during phenylephrine:

Alternative agents (if phenylephrine unavailable or contraindicated):

Systemic adjuncts:

Disease-specific systemic therapy:

Procedures — Aspiration, Irrigation, and Surgical Shunts

— Lidocaine 1% without epinephrine, 5–10 mL at 2 and 10 o'clock at penile base

— Alternative: subcutaneous ring block at penile base

— 19–21 gauge butterfly or angiocath into lateral corpus cavernosum at 2 or 10 o'clock (avoid dorsal NVB at 12, urethra at 6)

— Aspirate 20–60 mL of stagnant dark blood; send first 1–2 mL for blood gas

— Unilateral aspiration is usually sufficient (corpora communicate)

— 10–20 mL cold normal saline aliquots, repeated until aspirate is bright red and corpora detumescent

— Distal shunts (first line surgical):

— Winter shunt: percutaneous biopsy needle through glans into corpus cavernosum

— Ebbehoj shunt: scalpel stab through glans

— T-shunt (Lue): scalpel via glans with rotation; often combined with Burnett "snake" maneuver (tunneling with dilator) for prolonged priapism

— Al-Ghorab: open excision of distal tunica through glans

— Proximal shunts (if distal fail):

— Quackels (cavernosa-spongiosum) at penoscrotal junction

— Grayhack (cavernosa-saphenous vein)

— Higher ED rates; reserved for prolonged or refractory cases

— Considered at 36–72+ hours when corporal necrosis likely; preserves penile length and simplifies later implantation through fibrotic tissue

— Superselective transcatheter embolization of the lacerated cavernous artery using autologous clot or gelfoam; avoid permanent coils to preserve future erections

— Conservative observation alone resolves ~60% over weeks

CCS pearl: Advance the clock in 30–60 min increments after each intervention. Document the aspiration time, phenylephrine doses, and detumescence status; consult urology at presentation, escalate to OR for shunt at the 1-hour refractory mark.

Step 1: Dorsal penile nerve block

Step 2: Corporal aspiration

Step 3: Saline irrigation

Step 4: Intracavernosal phenylephrine (see chunk 7)

Step 5: Surgical shunts (if refractory after 1 hour of aspiration + phenylephrine):

Early penile prosthesis:

Non-ischemic priapism procedure:

Special Populations — Elderly and Renal/Hepatic Impairment

— Most common etiologies: intracavernosal injection therapy for ED, oral PDE-5 inhibitors combined with alpha-blockers or nitrates, antipsychotics initiated in long-term care

— Higher baseline cardiovascular comorbidity → intracavernosal phenylephrine requires cardiac monitoring, start with low dose (100 mcg), longer intervals (5 min)

— Greater risk of phenylephrine-induced hypertensive emergency, MI, stroke, arrhythmia

— Consider lower thresholds for early surgical shunt rather than prolonged sympathomimetic dosing

— Discuss realistic erectile function recovery — baseline ED is common; counsel that prolonged priapism worsens it

— Phenylephrine is hepatically metabolized; no major dose adjustment, but contrast for arteriography in non-ischemic disease requires renal-protective strategy (hydration, lowest contrast volume, avoid in eGFR <30 unless essential)

— Sickle cell nephropathy patients with priapism — monitor for AKI from rhabdo, contrast, and NSAID exposure

— Reduced phenylephrine clearance; use the lower end of dose range and lengthen intervals

— Avoid hepatotoxic adjuncts; acetaminophen dose-limited

— Coagulopathy from cirrhosis raises bleeding risk for aspiration and shunt — correct INR and platelets per institutional protocol before invasive procedures

— Trazodone (very common sleep aid in elderly), SSRIs, antipsychotics (especially second-generation), prazosin for BPH or PTSD

— PDE-5 inhibitors: tadalafil 5 mg daily for BPH/ED — verify dose; avoid concomitant alpha-1 blockers without spacing

— Anticoagulants (warfarin, DOACs) — adjust aspiration technique, hold or reverse if shunt needed

Step 3 management: Always reconcile medications at admission and again at discharge. In an elderly man with priapism on trazodone + tamsulosin + sildenafil PRN, the discharge plan must include discontinuing the offending agent and coordinating with the primary physician for an alternative regimen — failure to do so predicts recurrence and a malpractice claim.

Elderly men (>65):

Renal impairment:

Hepatic impairment:

Polypharmacy review (critical in elderly):

Special Populations — Pediatrics, Sickle Cell, and Other Subgroups

— Far less common than adult; in boys <18, sickle cell disease accounts for ~65%

— Other pediatric causes: leukemia (especially CML, acute leukemias), trauma, idiopathic, rare drug exposures

— Approach mirrors adult algorithm: dorsal nerve block, aspiration with blood gas, phenylephrine — dose-reduce phenylephrine to 5–10 mcg/kg per dose (max 250 mcg) in young children

— Cardiac monitoring is mandatory; avoid in known structural heart disease without cardiology input

— Engage pediatric urology, pediatric hematology, and child life early

— Concurrent care: IV fluids at maintenance (avoid over-hydration → ACS), supplemental O₂, opioid analgesia, treat any precipitating infection

— Simple transfusion to Hb 10 g/dL or exchange transfusion to HbS <30% for severe or refractory priapism

— Beware ASPEN syndrome: post-exchange neurologic events, especially headache, seizure — manage BP carefully and consider gradual reduction of HbS

— Long-term: hydroxyurea, chronic transfusion in selected, oral pseudoephedrine or etilefrine for stuttering disease

— Newer/agents: leuprolide, bicalutamide, PDE-5 inhibitor low-dose chronic therapy — refer to urology

— Spinal cord injury: reflex priapism may complicate acute SCI; ischemic episodes treated standardly

— Hematologic malignancy: CML with WBC >100k → leukapheresis + hydroxyurea + chemotherapy; treat priapism in parallel

— Substance use disorder: cocaine and methamphetamine — counsel and refer to addiction services

— Transgender women on estrogen/spironolactone — rare, typically resolves with hormonal adjustment

Board pearl: A boy with sickle cell disease and his third episode of self-resolving nighttime priapism this month has stuttering priapism — start outpatient pseudoephedrine or refer for hydroxyurea and counsel on home pseudoephedrine plus immediate ED return if any episode exceeds 4 hours.

Pediatric priapism:

Sickle cell disease (any age):

Pregnancy: N/A (male disease)

Other subgroups:

Complications and Adverse Outcomes

— Ischemic priapism >24 h: ED in ~50%

— Ischemic priapism >36 h: ED in 75–90%

— Ischemic priapism >48–72 h: near-universal severe ED with corporal fibrosis

— Non-ischemic priapism: ED uncommon, often resolves spontaneously or after embolization

— Result of smooth muscle necrosis and replacement with fibrotic tissue

— Makes future penile prosthesis implantation technically difficult — basis for early prosthesis placement strategy in prolonged ischemic cases

— Aspiration: hematoma, infection, urethral injury (if midline puncture), persistent fistula at puncture site

— Shunt: skin necrosis, urethrocutaneous fistula (proximal shunts), worsening ED, pulmonary embolism (Grayhack), recurrence

— Embolization (non-ischemic): gluteal claudication, perineal ulceration, recurrence if incomplete; permanent coils cause permanent ED

— Phenylephrine: severe hypertension, reflex bradycardia, headache, MI, stroke, ventricular arrhythmia

— Pseudoephedrine: insomnia, hypertension, tachycardia

— Sickle cell: vaso-occlusive crisis, acute chest syndrome, AKI, ASPEN syndrome post-exchange

— Leukemia: tumor lysis with cytoreduction, leukostasis-related stroke

— Depression, anxiety, relationship strain, post-traumatic stress related to genital injury and prolonged hospital course — frequently under-recognized

— Body image distress particularly in adolescents

Key distinction: The single most important driver of permanent ED is time to detumescence in ischemic priapism, not the technique used. The right answer to "how do we prevent ED?" is earlier presentation and earlier intervention, not a fancier shunt — emphasize this in patient education and stuttering priapism action plans.

Erectile dysfunction (the dominant complication):

Corporal fibrosis and penile shortening:

Procedure-related complications:

Pharmacologic complications:

Disease-specific complications:

Psychological:

When to Escalate Care — Consults and Disposition

— ED physician initiates aspiration and phenylephrine; urology takes over for shunt, OR, and admission

— Document time of consult call and bedside arrival

— Schedules selective pudendal arteriography with embolization; usually within 24–72 h, not emergent

— Any sickle cell patient (manage transfusion, hydroxyurea optimization)

— Suspected leukemia with hyperleukocytosis — urgent same-day consult for leukapheresis

— Hemodynamic instability from phenylephrine response

— Acute chest syndrome or stroke complicating sickle priapism management

— Hyperleukocytosis with leukostasis (respiratory failure, altered mental status)

— Post-exchange transfusion with ASPEN syndrome

— Post-shunt patients with significant blood loss, sepsis, or cardiac comorbidity

— Ischemic priapism requiring shunt — admit for monitoring, pain control, sitz baths, antibiotic prophylaxis

— Sickle cell patients post-exchange — admit for monitoring of hemolysis and neurologic status

— Detumescence achieved with aspiration ± phenylephrine, observation 1–2 h confirms no recurrence

— Pain controlled, urinating without difficulty

— Reliable follow-up arranged with urology within 1–2 weeks

— Offending medication discontinued or substituted, patient counseled

— Facility lacking urology or IR coverage should transfer after initiating aspiration and phenylephrine if priapism persists beyond 1 hour, ideally before 12-hour mark

CCS pearl: In CCS, the case advances differently for low-flow vs high-flow. Low-flow: order urology consult, aspiration, phenylephrine, then advance time in 30-min blocks reassessing the corpora. High-flow: order urology consult, schedule outpatient IR arteriography, discharge home with ice and follow-up. Choosing the wrong pathway costs points.

Urology consultation — call at presentation, every case:

Interventional radiology — for confirmed non-ischemic priapism:

Hematology consultation:

ICU admission criteria:

Floor/ward admission:

Outpatient discharge from ED — appropriate when:

Transfer considerations:

Key Differentials — Same-Category (Genitourinary) Causes

— Normal prolonged erection / nocturnal tumescence: <4 h, glans and corpus spongiosum fully engorged, no pain

— Stuttering priapism: repeated ischemic episodes, each <4 h, self-resolving; in sickle cell or chronic PDE-5i users — needs prophylaxis, not emergent shunt during quiescent phase

— High-flow (non-ischemic) priapism: partial, painless, post-trauma — managed with embolization

— Low-flow (ischemic) priapism: painful, rigid, dark blood — emergent

— Retracted foreskin trapped behind glans → glans edema and pain

— Penile shaft is flaccid; only glans is swollen and tender

— Treatment: manual reduction with ice/compression; dorsal slit if refractory

— Sudden snap during intercourse, immediate detumescence, swelling, eggplant deformity, ecchymosis

— Not a persistent erection — opposite presentation

— Surgical repair within 24 h

— Painful curved erection with palpable dorsal plaque; chronic, not emergent

— Distended bladder, not corpora

— Erythema, crepitus, systemic toxicity — emergent surgical debridement

— Pain on voiding, discharge — distinct

— Indurated mass, ulceration — not acutely erect

— Palpable cord along dorsal aspect, no corporal involvement

Board pearl: A painful glans with a flaccid shaft = paraphimosis, not priapism. A rigid shaft with a soft glans = priapism. This single-line discriminator separates the two most-tested male GU emergencies on Step 3.

Differentiate within "persistent erection" and other GU pathologies:

Paraphimosis:

Penile fracture:

Peyronie's disease:

Phimosis with urinary retention:

Penile cellulitis or Fournier's gangrene:

Urethral foreign body or urethritis:

Penile carcinoma:

Penile thrombosis (Mondor's disease of dorsal vein):

Key Differentials — Other-Category Causes

— CML: painless splenomegaly, WBC often >100k with myeloid left shift; priapism from leukostasis — need urgent CBC with differential, hydroxyurea, leukapheresis

— Acute leukemia: blasts on smear, fatigue, bleeding

— Multiple myeloma: hyperviscosity (rare cause), back pain, renal failure, hypercalcemia, anemia

— Polycythemia vera: JAK2 mutation, hyperviscosity

— Sickle cell disease: as discussed; consider in any African ancestry patient with priapism

— Spinal cord injury (acute or chronic) — reflex erection, often misclassified; corporal gas distinguishes

— Cauda equina syndrome — saddle anesthesia, urinary retention, bilateral leg weakness

— Cerebrovascular events affecting autonomic pathways — rare

— Trazodone (classic Step 3 trigger), SSRIs (citalopram, paroxetine), antipsychotics (chlorpromazine, risperidone, olanzapine, quetiapine), prazosin, terazosin, hydralazine, anticoagulants, papaverine, alprostadil, cocaine, methamphetamine, cannabis, alcohol

— Total parenteral nutrition with high-fat content (rare, ICU patients)

— Fabry disease (rare), amyloidosis with vascular involvement

— Rabies, scorpion stings (regional), malaria with vascular sludging — exotic but classic

— Metastatic prostate, bladder, rectal, renal cancer infiltrating corpora — MRI confirms; cancer-specific treatment

Step 3 management: When priapism is the presenting symptom of leukemia or sickle cell, the urology evaluation is only half the workup — order CBC with differential and reticulocyte count on every priapism patient. A 35-year-old with a first priapism, splenomegaly, and WBC 180k has CML until proven otherwise and needs same-day heme/onc, leukapheresis, and hydroxyurea, not just aspiration.

Hematologic mimics presenting with priapism as a clue:

Neurologic mimics:

Pharmacologic and toxicologic:

Metabolic/endocrine:

Infectious/inflammatory:

Malignant infiltration:

Secondary Prevention, Discharge Medications, and Long-Term Plan

— Stop the offending agent — trazodone, SSRI, antipsychotic, prazosin, intracavernosal injection therapy; coordinate alternative with prescriber

— Oral pseudoephedrine 30–60 mg as needed for early home recurrence (>4 h triggers ED return regardless)

— Acetaminophen ± short opioid course for post-aspiration pain

— Sitz baths, scrotal support, avoidance of sexual activity for 4 weeks or until cleared by urology

— Antibiotic prophylaxis only if shunt or significant instrumentation (e.g., cephalexin 7 days)

— Counsel: any new erection >2 h → take pseudoephedrine and consider exercise; >4 h → ED immediately

— Hydroxyurea — disease-modifying, reduces frequency

— Daily oral pseudoephedrine 30–60 mg at bedtime or etilefrine (where available)

— Low-dose daily PDE-5 inhibitor (sildenafil 25–50 mg or tadalafil 5 mg) — paradoxically reduces stuttering episodes by normalizing endothelial NO signaling; start only between episodes, not during acute

— Hormonal therapy (leuprolide, bicalutamide, finasteride) — refer to urology for refractory cases

— Chronic transfusion in selected cases

— Outpatient urology follow-up at 2 and 6 weeks; recurrence common if embolization incomplete

— Repeat duplex US to confirm fistula closure

— Early urology referral for PDE-5 inhibitor trial, intracavernosal injection therapy (controversial after priapism), vacuum erection devices

— Penile prosthesis discussion at 3–6 months if persistent ED

— Discontinue cocaine, methamphetamine — refer to addiction services

— Counsel on safe PDE-5 inhibitor dosing; avoid combining with nitrates or supratherapeutic doses

Board pearl: A patient discharged after trazodone-induced priapism whose primary care physician restarts trazodone for insomnia at the next visit represents a transition-of-care safety failure — always communicate the offending agent in the discharge summary and call the prescriber directly when feasible.

Discharge after acute ischemic priapism (resolved):

Sickle cell stuttering priapism — long-term regimens:

Post non-ischemic priapism (post-embolization):

After prolonged ischemic priapism with anticipated ED:

Lifestyle and behavioral:

Follow-Up, Monitoring, and Rehab/Counseling

— Urology visit within 1–2 weeks for all priapism patients

— Hematology within 1–2 weeks for sickle cell or hyperleukocytosis-related cases

— Primary care within 1 week for medication reconciliation

— Interventional radiology follow-up at 2 and 6 weeks post-embolization with duplex US

— Penile prosthesis surgical planning at 3–6 months if ED persists

— Erectile function: International Index of Erectile Function (IIEF-5) at baseline and serial visits

— Pain: visual analog scale

— Recurrence: patient diary of any erection >2 h or painful erection

— For sickle stuttering: episode frequency, hydroxyurea response (MCV, HbF, Hb)

— Cardiovascular: BP monitoring if chronic pseudoephedrine therapy

— Penile rehabilitation with low-dose daily PDE-5 inhibitor may improve smooth muscle recovery in some patients with prolonged ischemic priapism — urologist-directed

— Vacuum erection device after wound healing

— Couples counseling and sex therapy referral for psychological impact and partner adjustment

— Adolescent patients: confidentiality, age-appropriate education, school accommodation if hospitalized

— Red-flag teaching: any erection >4 h is an emergency; ED, do not wait

— Carry a card noting sickle cell status and prior priapism episodes (helps EDs initiate care quickly)

— Avoid PDE-5 inhibitors with nitrates, recreational stimulants, alcohol excess

— Many priapism medications (intracavernosal phenylephrine, hydroxyurea, PDE-5 inhibitors) have insurance/prior auth barriers — start the process at discharge

— Telehealth follow-up acceptable for medication review; in-person required for genital exam

Step 3 management: Document a clear written action plan ("If your erection lasts more than 2 hours, take pseudoephedrine X mg; if >4 hours or painful, go directly to the ED") and ensure the patient verbalizes understanding. Action plans cut recurrence ED visits and improve outcomes — high-yield ambulatory medicine principle.

Follow-up timeline:

Monitoring parameters:

Rehabilitation and sexual health counseling:

Patient education priorities:

Health-system considerations:

Ethical, Legal, and Patient Safety Considerations

— Aspiration, dorsal nerve block, intracavernosal phenylephrine, and surgical shunts each require informed consent — discuss risk of ED, fistula, infection, and recurrence

— For prolonged ischemic priapism, discuss the trade-off: aggressive shunting vs early penile prosthesis; document shared decision-making

— In emergency life- or organ-threatening situations with an unconscious patient, implied consent allows aspiration and phenylephrine to preserve erectile function, but document the necessity

— Parental consent required for minors; obtain assent from adolescents

— In sickle cell adolescents, address confidentiality regarding sexual history, substance use, and erectile concerns — many states allow minors to consent for STI, substance use, and reproductive care

— Priapism in a young child without sickle cell or leukemia raises concern for sexual abuse, accidental ingestion (parental medication), or non-accidental trauma — institutional child protection consult and mandated reporting

— Document carefully; involve social work

— Discharge summary must explicitly list the offending medication and instruction "do not restart"

— Direct communication with the prescribing physician (psychiatrist, primary care) reduces recurrence

— Medication reconciliation at every subsequent visit

— Limit number of providers at the bedside; chaperone for genital exam

— Avoid hallway exam; private room and gown; trauma-informed approach especially in pediatric and SCI patients

— Sickle cell patients face documented disparities in pain control and analgesia — ensure adequate opioid dosing and avoid stigmatizing language

— Insurance/cost barriers to hydroxyurea, exchange transfusion, and IR procedures may require social work intervention

— Document duration of erection, time of each intervention, response, and consult times — central to defensibility if ED results

— Failure to consult urology promptly is a frequent litigation issue

Step 3 management: A 6-year-old with isolated priapism and no hematologic disease warrants both a hematologic workup and a child protection consult — both branches of the differential matter, and missing either is a patient safety failure.

Informed consent for invasive procedures:

Adolescent and pediatric consent:

Mandatory reporting and abuse considerations:

Transition-of-care safety:

Patient confidentiality and dignity:

Disparities and access:

Liability and documentation:

High-Yield Associations and Rapid-Fire Clinical Facts

— Trazodone → ischemic priapism (classic Step 3 trigger)

— Intracavernosal alprostadil/papaverine → ischemic priapism

— Sickle cell disease → stuttering and ischemic priapism

— CML with WBC >100k → leukostatic priapism

— Cocaine, methamphetamine → ischemic priapism

— Perineal straddle injury → high-flow (non-ischemic) priapism

— Spinal cord injury → reflex priapism

— Antipsychotics (chlorpromazine, risperidone, olanzapine) → ischemic priapism

— Prazosin (alpha-1 blocker) → ischemic priapism

— Soft glans + soft spongiosum + rigid cavernosa = priapism (cavernosa-only finding)

— Corporal pO₂ <30, pCO₂ >60, pH <7.25 = ischemic

— Corporal pO₂ >90, bright red blood = non-ischemic

— Duplex US: low/absent flow = ischemic; turbulent fistula jet = non-ischemic

— Phenylephrine 100–500 mcg intracavernosal q3–5 min, max ~1 mg/h

— Aspirate 20–60 mL from 2 or 10 o'clock with dorsal nerve block

— Sickle cell: hydration, O₂, analgesia, transfusion to HbS <30% — but do not delay aspiration

— Non-ischemic: ice + observation → superselective embolization with autologous clot

— Distal shunt before proximal shunt

— Early penile prosthesis at 48–72 h if corporal necrosis

— >4 h = emergency

— >24 h = ED in ~50%

— >36 h = ED in 75%+

— >72 h = near-universal severe ED, consider early prosthesis

— Phenylephrine (acute), pseudoephedrine (oral/home), hydroxyurea (sickle), leuprolide/bicalutamide (refractory stuttering), low-dose PDE-5i (paradoxical prevention)

Board pearl: "Trazodone + young man + painful erection 6 hours" → ischemic priapism → corporal blood gas + aspiration + intracavernosal phenylephrine. Memorize this single chain; it appears in some form on virtually every Step 3 priapism question.

Disease–trigger associations (memorize):

Diagnostic pearls:

Treatment pearls:

Time and outcome:

Drugs to know:

Board Question Stem Patterns

— 32-year-old man with depression on trazodone presents with painful rigid erection for 6 hours. Best next step?

— Answer: aspiration of corpus cavernosum with intracavernosal phenylephrine (after dorsal nerve block)

— 19-year-old with HbSS reports three nighttime erections lasting 2–3 hours over the past month. Best long-term management?

— Answer: hydroxyurea ± oral pseudoephedrine at bedtime; ED return for any episode >4 h

— 17-year-old fell on bicycle bar 3 days ago, now with painless partial erection. Aspirate bright red blood. Best next step?

— Answer: selective pudendal arteriography with superselective embolization (autologous clot)

— 38-year-old man with painful erection, splenomegaly, WBC 200,000 with myeloid left shift. Best next step?

— Answer: leukapheresis + hydroxyurea + heme/onc consultation; concurrent local management

— Boy with sickle priapism received exchange transfusion, now has headache and seizure. Diagnosis?

— Answer: ASPEN syndrome — manage BP, neurology consult

— Man with 40-hour priapism unresponsive to two rounds of aspiration and phenylephrine. Best next step?

— Answer: surgical distal shunt (Winter/Ebbehoj/T-shunt), consider tunneling

— 4-year-old boy with isolated priapism, no hematologic history. Best next step?

— Answer: hematologic workup and child protection consultation

— Patient resolved from antipsychotic priapism, being discharged. Best step?

— Answer: discontinue offending antipsychotic, coordinate alternative with psychiatry, document in discharge summary

Key distinction: Painful + rigid = aspiration + phenylephrine immediately. Painless + post-trauma = embolization, not aspiration. Mixing these up is the single most common board error on this topic — anchor on pain and corporal gas, not on duration alone.

Pattern 1 — Trazodone-induced ischemic priapism:

Pattern 2 — Sickle cell stuttering priapism:

Pattern 3 — Non-ischemic post-traumatic priapism:

Pattern 4 — Leukemia presenting as priapism:

Pattern 5 — Sickle exchange transfusion complication:

Pattern 6 — Refractory ischemic priapism timing:

Pattern 7 — Pediatric/abuse stem:

Pattern 8 — Discharge medication safety:

One-Line Recap

Ischemic priapism is a time-critical urologic emergency treated with bedside corporal aspiration, irrigation, and intracavernosal phenylephrine — escalating to surgical shunting after 1 hour of failed medical therapy — whereas non-ischemic priapism is a post-traumatic high-flow arteriovenous fistula managed electively with selective pudendal embolization.

Three diagnostic anchors: pain + rigidity + dark corporal blood gas (pO₂ <30, pCO₂ >60, pH <7.25) define ischemic; painlessness + bright red aspirate + perineal trauma define non-ischemic; corporal cavernosa rigid with soft glans and spongiosum confirms priapism, not paraphimosis or normal erection.

Three treatment anchors: intracavernosal phenylephrine 100–500 mcg q3–5 min with cardiac monitoring is first-line for ischemic; distal shunt (Winter, Ebbehoj, T-shunt) before proximal (Quackels, Grayhack); early penile prosthesis at 48–72 hours when corporal necrosis is anticipated.

Three systemic anchors: sickle cell disease requires hydration, oxygen, analgesia, and exchange transfusion to HbS <30% without delaying local therapy; CML with hyperleukocytosis requires leukapheresis and hydroxyurea; offending medications (trazodone, SSRIs, antipsychotics, prazosin, intracavernosal ED agents, cocaine) must be discontinued at discharge with direct prescriber communication.

Three longitudinal anchors: ED risk rises steeply after 24 hours and is near-universal after 72 hours, making time-to-treatment the single most important determinant of outcome; stuttering priapism in sickle cell warrants hydroxyurea, bedtime pseudoephedrine, and potentially low-dose daily PDE-5 inhibitor for paradoxical prevention; every discharge must include a written action plan ("erection >2 h → pseudoephedrine; >4 h → ED") and urology follow-up within 1–2 weeks.